Keyphrases
Scleromyxedema
100%
Molecular Phenotype
100%
Clinical Phenotyping
100%
Intravenous Immunoglobulin (IVIg)
100%
Intravenous Immunoglobulin Therapy
100%
Skin Thickness Score
60%
Skin Involvement
40%
Skin Flexibility
20%
Skin Tissue
20%
Body Surface Area
20%
CCR4
20%
Biochemical Changes
20%
Clinical Change
20%
Interferon Pathway
20%
Tc17
20%
CXCR3
20%
CCR6
20%
Skin Biopsy
20%
Clinical Improvement
20%
Interferon-induced Protein
20%
Medicine and Dentistry
Intravenous Immunoglobulin Therapy
100%
Lichen Myxedematosus
100%
Interferon
40%
Systemic Scleroderma
20%
Body Surface
20%
Skin Biopsy
20%
Immunology and Microbiology
Intravenous Immunoglobulin Therapy
100%
Surface Area
20%
Body Surface
20%
CCR4
20%
Peripheral Blood Mononuclear Cell
20%
Systemic Scleroderma
20%
CXCR3
20%
Pharmacology, Toxicology and Pharmaceutical Science
Scleromyxedema
100%
CD8 Antigen
20%
Systemic Sclerosis
20%
Neuroscience
Interferon
25%
Peripheral Blood Mononuclear Cell
12%
CD8
12%
CCR4
12%